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Abstract
Microsatellite repeats are genetically unstable and subject to expansion and shrinkage. A
subset of them, triplet repeats, can occur within the coding region and specify homomeric
tracts of amino acids. Polyglutamine (polyQ) tracts are enriched in eukaryotic regulatory
proteins, notably transcription factors, and we had shown before that they can contribute to
transcriptional activation in mammalian cells. Here we generalize this finding by also
including evolutionarily divergent organisms, namely, Drosophila and baker's yeast. In all
three systems, Gal4-based model transcription factors were more active if they harbored a
polyQ tract, and the activity depended on the length of the tract. By contrast, a polyserine tract
was inactive. PolyQs acted from either an internal or a C-terminal position, thus ruling out a
merely structural "linker" effect. Finally, a two-hybrid assay in mammalian cells showed that
polyQ tracts can interact with each other, supporting the concept that a polyQ-containing
transcription factor can recruit other factors with polyQ tracts or glutamine-rich activation
domains. The widespread occurrence of polyglutamine repeats in regulatory proteins suggests
a beneficial role; in addition to the contribution to transcriptional activity, their genetic
instability might help a species to adapt to changing environmental conditions in a potentially
reversible manner.
Keywords: Drosophila, polyglutamine repeat, S. cerevisiae, transcription factor, triplet
repeat.
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Introduction
PolyQs are the most frequent type of homo-amino acid tracts found in the Drosophila
melanogaster proteome (Bettencourt et al., 2007). At least 30 Drosophila proteins possess
polyQ tracts of 20 residues or longer, which are conserved in other drosophilid species. In the
human proteome there are several prevalent homo-amino acid tracts, whereby polyQ tracts are
the most frequent homo-amino acid tracts encoded by repeats of a single codon (CAG)
(Kozlowski et al., 2010). Screening of the Saccharomyces cerevisiae protein database
(www.yeastgenome.org) revealed that polyQ tracts are the most common homopolymeric
amino acid tracts of eight amino acids length or longer. Functional association analysis
showed that the most prevalent triplet repeats found in human ORFs (CGG coding for
alanine, CAG - glutamine, CCG - proline, AGG - glutamic acid, ACC - histidine)
predominantly occur in genes associated with transcription-related functions (Bettencourt et
al., 2007). For example, transcriptional regulators such as Snf5 and Gal11 in S. cerevisiae,
prospero and dClock in Drosophila and TATA-box binding protein (TBP), forkhead box
protein P2 (FoxP2) and the androgen receptor in humans contain polyQ tracts of at least 20
residues. In most of the above-mentioned transcription factors the role of the polyQ tract was
not studied, but in a synthetic transcription factor polyQs have been demonstrated to be able
to increase the transactivation potential (Gerber et al., 1994). Furthermore, many regulators of
transcription contain glutamine-rich activation domains that are important for protein-protein
interactions and gene expression regulation (Courey and Tjian, 1988; Seipel et al., 1992).
PolyQ tracts encoded by CAG repeats are particularly problematic due to their genetic
instability caused by out-of-register recombination or DNA strand slippage during replication
(Gao et al., 2008), an effect that was also observed with other types of short repeats (e.g., Bois
et al., 2001). Nine human neurodegenerative disorders, all of them inherited gain-of-function
diseases, are caused by the expansion of CAG repeats. These include Huntington’s disease,
spinobulbar muscular atrophy (SMBA or Kennedy’s disease), several forms of
spinocerebellar ataxia (SCA-1, -2, -3, -6, -7, -17) and dentatorubral pallidoluysian atrophy
(Gusella and MacDonald, 2000; Mirkin, 2007; Orr and Zoghbi, 2007). The critical maximal
length of polyQ tracts in eukaryotes is usually 35-40 residues. Longer polyQ tracts are prone
to self-aggregation into fibrils, wherein the polyQs form stable “polar zippers” of β-barrels, in
agreement with a so-calledβ-helix nanotube model (Merlino et al., 2006; Perutz et al., 1994;
Perutz et al., 2002). A main feature of polyQ associated diseases are intraneural aggregates of
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proteins with expanded polyQ tracts. Large insoluble aggregates “inclusion bodies” might
even have a protective role in affected cells by preventing the alternative formation of many
small, more deleterious oligomeric aggregates (Arrasate et al., 2004; Miller et al., 2010;
Saudou et al., 1998; Sánchez et al., 2003).
Transcriptional dysregulation has been implicated in several polyQ diseases (Riley and Orr,
2006; Sugars and Rubinsztein, 2003). Expanded polyQ tracts can interact with polyQ-
containing or other transcription factors and co-factors and thus interfere with their normal
function. Target proteins can be sequestered by polyQ-protein monomers or recruited into
aggregates (Helmlinger et al., 2006; Kazantsev et al., 1999; Okazawa, 2003; Huang et al.,
2011; Friedman et al., 2007). Of note, aberrant polyQ interactions were described for CREB-
binding protein (CBP), p53, Sp1 and TAFII130 and are associated with impaired transcription
(Dunah et al., 2002; Bae et al., 2005; Nucifora et al., 2001). Furthermore expanded
trinucleotide repeat sequences within the mRNA can be toxic for the cell and contribute to
disease symptoms (Li and Bonini, 2010).
We postulated before that the genetic instability of polyamino acid tracts, notably of polyQs,
has a beneficial role in evolution since it allows for the modulation of transcription factor
activity (Gerber et al., 1994; see also Künzler et al., 1995). Here we generalize the earlier
findings with mammalian cells by including the model systems of Drosophila and yeast, and
we propose that variable repeats located in certain key proteins are used as “evolutionary
tools” or ‘tuning knobs’, to facilitate potentially reversible adaptations to changing
environmental conditions.
Results
Polyglutamines contribute to transcriptional activation in a reporter system
driven by a synthetic transcription factor
To test the influence of a polyQ-tract on transcriptional activation, we generated chimeric
transcription factors in which the DNA-binding domain of yeast Gal4 (Gal4DBD) was linked
via polyQ tracts of various length to the strong activation domain of the herpes simplex virus
protein VP16 (VP16AD80) or to the N-terminal half of it (VP16AD40) (Figure 1A and C). The
number of glutamine residues was chosen such that it corresponds to the naturally occurring
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non-pathogenic size (20Q), close to pathogenic size (40Q) or expanded abnormal length
(86Q). When tested in Drosophila cell culture, polyQ tracts had a positive effect on
transcription efficiency (Figure 2A). Reporter gene transcript levels were highest with 40Q-
and were also elevated with 20Q- and 86Q-containing effector proteins compared to the one
without polyQ.
Next we produced transgenic Drosophila strains containing the chimeric transcription factors
and tested them with a UAS-GFP reporter system. We found that polyQs also contributed to
transcriptional activation in vivo, whereby flies with the 86Q-containing transcription factor
showed a stronger GFP signal than the ones with 20Q (Figure 2B). A positive correlation
between transactivation potential and the length of the polyQ tract was also observed with a
UAS-lacZ reporter (Figure 2C).
Together with polyasparagine, polyproline and polyglutamic acid, polyQs are often found in
proteins that are involved in basal and regulated transcription in baker’s yeast. To test the
polyQ-containing transcription factors in yeast we used an in vivo plate assay with X-Gal in
the medium and the liquid lacZ-assay. As in mammalian cells and Drosophila, in yeast the
synthetic transcription factors carrying polyQ tracts of various sizes activated transcription of
a LacZ reporter gene in a polyQ length-dependent manner (Figure 2D and 2E). In our yeast
studies a less active subsegment of the VP16 activation domain (VP16AD40) was used to
avoid selection against the very potent and possibly toxic full-length activation domain
(Sadowski et al., 1988), and also to retain the possibility to increase transactivation by
introducing a polyQ stretch.
To test whether the increased activity conferred by the polyQ tract was position specific (i.e.
confined to the linker region between the DNA-binding and activation domains) or was a
more general phenomenon, we placed the polyQ tract at the C-terminus of chimeric
transcription factors, containing the activation domain of either Gal4 or VP16 (Figure 1B). A
C-terminally located polyQ-tract also boosted transcription, although the effect was not as
pronounced as with an internal polyQ “linker” (Figure 3).
Polyglutamines, but not polyserines stimulate transcription
Poly[CAG] can be translated, depending on the reading frame, into three different
homopolymeric amino acid stretches, namely, polyglutamine, polyserine and polyalanine.
Homopolymeric serine tracts have been reported to behave in a neutral manner with regard to
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transcriptional activity, whereas polyalanines act as transcriptional repressors (Lanz et al.,
1995). In HEK293T cells the constructs with 20 or 86 serines between Gal4DBD and
VP16AD80 did not increase transcriptional activity (Figure 4A). A polyserine tract also had no
effect in Drosophila (Figure 4B). These results show that activation by polyQ tracts located
between DNA-binding and activation domain is not merely a linker effect, in line with the
finding that a polyQ tract was also active if added at the C-terminus (see above).
Transactivation via polyglutamine interactions tested in a mammalian two-
hybrid system
It has been reported that polyQ domains of proteins can interact with other polyQ-containing
or glutamine-rich transcription factors (Chen et al., 2004). In order to test for polyQ-polyQ
interactions in vivo, we generated a mammalian two-hybrid system where a polyQ tract fused
to the Gal4DBD acts as a ‘bait’ and a polyQ tract fused to the VP16AD80 as a ‘prey’ (Figure
1D). The interaction between the two polyQ-containing proteins indeed induced transcription
in HEK293T cells, as shown by the S1-nuclease protection assay, whereby longer polyQs on
one or both partners gave stronger signals (Figure 5A). A bandshift assay showed that all of
the bait constructs were similarly expressed. However, the interaction between polyQ-
containing bait and prey proteins is probably weak, as no supershift with the prey was
observed in EMSA assays (Figure 5B). We could not observe a two-hybrid interaction in
other cell lines and in Drosophila (data not shown), likely because HEK293T cells take up
and express transfected DNA most efficiently.
Discussion
Despite their genetic instability, especially their tendency to expand and the potential to cause
neurodegeneration, polyQs are a widespread feature in eukaryotic proteomes, from yeast to
humans, and are enriched in transcription factors and transcriptional regulators. The presence
of polyQ tracts in so many proteins, notably in DNA-binding transcription factors and co-
factors, suggests a functional role. It was previously shown in mammalian cells that
glutamine-rich domains can synergize with acidic activation domains (Seipel et al., 1992).
Indeed, introduction of a polyQ stretch into a synthetic transcription factor increased its
transcriptional activity. By varying the size of the polyQ stretch within a transcription factor
we could modulate its activity. A similar effect was observed for the androgen receptor,
PolyQ tract generally activates transcription
7 / 20
however with a negative correlation between polyQ length and transcription factor activity
(Chamberlain et al., 1994; Wang et al., 2004). A positive or negative correlation of repeat
number and protein activity is not confined to homomeric poly-amino acid tracts: for
example, cell adhesion in yeast is influenced by the repeat number of a subdomain in the
flocculation protein Flo1 (Verstrepen et al., 2005).
Transcriptional activation in vivo is optimal for a certain number of repeats; in our case
introducing 40Q resulted in the highest transcriptional activity (even stronger than 86Q) in
mammalian cells and in Drosophila. The lower activity with 86Q might be explained by the
propensity of oversized polyQ tracts to aggregate and thereby inactivate a fraction of the
chimeric transcription factor. Somewhat surprisingly, the synthetic transcription factor with
86Qs was the most potent one in yeast, even though the physiological upper limit for polyQ
tracts in yeast, like in Drosophila and mammals, is around 40Q.
The type of glutamine-encoding triplet (CAA or CAG) and their degree of intermingling is
critical for the genetic stability of repeat size and therefore in the development polyQ-
associated neurological disorders. Pure CAG repeats are less stable than repeats encoded by a
mix of interspersed CAG and CAA triplets (Gao et al., 2008). An example of the latter is
FoxP2, a transcription factor needed for speech and language development in humans, with a
long, quite stable polyQ stretch of 40 glutamines (Bruce and Margolis, 2002; Webb and
Zhang, 2005; Enard and Przeworski, 2002). Most likely, CAA interruptions counteract CAG
repeat slippage and -expansions in DNA. CAA interruptions also play a role in the mRNA
folding of the repeat region in SCA2, SCA1, TBP, FoxP2, MAML2 transcripts: depending on
the number and frequency of CAA interruptions, polyQ transcripts exhibit different secondary
structures, such as short or long hairpins, or no hairpins at all (Sobczak and Krzyzosiak,
2005).
We have shown that polyglutamines can increase the activity of a transcription factor in
diverse model organisms from yeast to mammals. However, the same effect could in principle
be achieved without polyQ stretch by simply making a standard activation domain more
potent. Thus the question of the biological role of polyglutamine tracts remains. We
postulated before that genetically unstable polyamino acid tracts have a positive role in
evolution: by modulating transcription factor activity they might result in subtle or overt
alterations of an organism's genetic program (Gerber et al., 1994). In recent years, much
attention has been given to reversible epigenetic modifications and their role in the adaptation
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to new ecological niches. Heritable alterations in the length of polyglutamine tracts, which in
principle are readily reversible, represent an intermediate state between classical DNA
mutations and epigenetic changes via chromatin proteins and DNA methylation. Whether
environmental conditions can influence the direction of such semi-stable genetic alterations,
as was speculated by us (Künzler et al.,1995), remains to be seen.
Materials and methods
Plasmid constructions
Reporter and reference plasmids for mammalian and Drosophila cell culture transcription
experiments are based on the OVEC system (Westin et al., 1987). Gal4DBD-nQ-VP16AD80
plasmids (whereby n indicates the number of glutamine residues), driven by the CMV
promoter in the pSCT vector were described previously (Gerber et al., 1994). For expression
vectors encoding Gal4DBD-nQ-VP16AD fusion proteins (Figure 1A) that were inserted into
the Drosophila genome via the φC31 system (Bischof et al., 2007) the inducible 183 bp
metallothionein B promoter was inserted in between SalI and SacI sites. While constructs
driven by the strong Actin promoter could be used in cell culture, we could not obtain
transgenic Drosophila with these constructs, possibly due to the toxicity of the construct. The
40 carboxyl terminal CAG codons followed by a stop codon were inserted into the AgeI site
of plasmids Gal4DBD-GalAD and Gal4DBD-VP16AD80, in this case both driven by the
Drosophila Actin promoter (Figure 1B).
For experiments in S. cerevisiae we used the high copy number pAS2ΔΔ vector, where 
fusions of Gal4DBD with the N-terminal 40 amino acids of VP16AD (VP16AD40) were
driven by the yeast alcohol dehydrogenase 1 (ADH1) promoter (Figure 1C). VP16AD40 ,
encompassing only the N-terminal half of the strong VP16 activation domain, was generated
by introducing several stop codons into VP16AD80.
“Prey” and “bait” constructs for two-hybrid studies (Gal4DBD-nQ and nQ-VP16) were
generated by removing either the Gal4DBD or the VP16AD moieties from the CMV-driven
Gal4DBD-nQ-VP16 constructs. Untypical polyQ sizes (26 or 74Q) were the result of
instability of triplet repeats during the cloning procedure (Figure 1D).
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Detailed information about plasmid sequences and cloning strategies is available upon
request.
Cell culture and transfections
Culturing and transfection of human embryonic kidney 293T (HEK293T) cells was carried
out in Dulbecco’s Modified Eagle Medium (DMEM, GIBCO, Invitrogen) supplemented with
10% fetal bovine serum (Biochrom AG), 100 U/ml penicillin, 100μg/ml streptomycin and 2
mM L-glutamine (Invitrogen). Reporter and reference genes were transfected into cells
together with the expression vectors by the calcium-phosphate co-precipitation method
(Graham and van der Eb, 1973; Wigler et al., 1987). 16 hours after transfection cells were
washed with TBS and incubated for 24 hours in growth medium before harvesting them for
RNA extraction or nuclear protein extract preparation. For transfections, a total of 20μg DNA
adjusted with herring sperm DNA was used per 10 cm cell culture dish. Drosophila Schneider
2 (S2) and Kc cells were cultured in Schneider’s Drosophila medium (GIBCO, Invitrogen)
containing 10% heat-inactivated fetal bovine serum (Biochrom AG), 100 U/ml penicillin and
100 μg/ml streptomycin. As for mammalian cells, the calcium-phosphate co-precipitation
method was used for transfections. Cells were harvested for further manipulations 48 or 72
hours after transfection.
S1 nuclease protection assay
Exponentially growing cells in a 10 cm culture dish were transfected with 1-5 μg of the
particular expression plasmids, 10-20 μg of reporter and 1-10 μg of reference plasmid, as
indicated in the figure legends. The isolation of RNA and the S1 nuclease protection assay
were performed as described previously (Westin et al., 1987; Weaver and Weissmann, 1979),
with 100 -150 μg of total RNA per sample. Signals were visualized using the fluorescent
image analyzer FLA-7000 and quantified using the ImageGauge software (Fujifilm Life
Science). Reporter signals were normalized to the reference signals.
Electrophoretic mobility shift assay
Mammalian HEK293T cells were transiently transfected with the respective constructs and
collected 48 hours later. Electrophoretic mobility shift assays (EMSAs) were performed as
described in (Radtke et al., 1993) and (Zhang et al., 2001). Binding reactions were performed
by incubating 20 fmol of [γ-32P]-ATP end-labeled oligonucleotides containing the DNA-
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binding site for Gal4 with 5 μg of nuclear extracts prepared according to (Schreiber et al.,
1993). Oligonucleotides used for EMSA are as follows (complementary base pairs are
indicated in capital letters):
5'-CGGATTAGAACCCTCCGCCgc-3'
3'-gtacGCCTAATCTTGGGAGGCGG-5'
Liquid lacZ assay with Drosophila larvae
For measuring β-galactosidase activity, samples consisting of three wandering larvae were
lysed by repeated freeze-thaw cycles in liquid nitrogen. The samples were vortexed with
100μl Z-buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4) for
20 seconds. 700 μl Z-buffer supplemented with 50 mM β-mercaptoethanol were added to
each sample. The reaction was started with 160 μl ONPG (ortho-nitrophenyl-β-galactoside)
substrate (4 mg/ml). After 5 min at 30ºC, 400μl of 1 M Na2CO3 were added and the samples
centrifuged for 10 min at 13’000 rpm. The OD of the clear supernatant was measured at
420 nm.
Yeast strains and gene expression
Yeast was grown in a rich YPD medium (2% glucose, 2% bacto-tryptone, 1% yeast extract)
or in a synthetic drop-out medium if selection for plasmid-dependent growth was required
(2% glucose, 0.17% yeast nitrogen base, 0.5% ammonium sulfate, 1x amino acid mix). The
following S. cerevisiae strains were used: Y190 (MATa, gal4-542, gal80-538, his3, trp1-901,
ade2-101, ura3-52, leu2-3,112, URA3::GAL1-LacZ, Lys2::GAL1-HIS3cyhr) and Y187
(MATα, ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 112, gal4Δ, met–, gal80Δ, MEL1,
URA3::GAL1UAS-GAL1TATA-lacZ). Gene expression in yeast was monitored by an in vivo plate
assay using X-Gal (bromo-chloro-indolyl-galactopyranoside) in the medium and by a
quantitative liquid culture assay using ONPG as substrate (CLONTECH protocols).
Fly food, transgenic fly strains
One liter of fly food was composed of 55 g cornmeal (Maisgriess 54.401.025, Meyerhans
Hotz AG), 100 g yeast (Hefe Schweiz AG), 75 g sugar (Dextrose monohydrate), 8 g agar
(Insectagar type ZN5) and 15 ml anti-fungal Nipagin (nipagin 33 g/l, nipasol 66 g/l (Brenutag
Schweizerhall AG, Basel, Switzerland) in 96% ethanol). For the induction of the MtnB
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promoter, food was supplemented with CuSO4 to 100 μM. Transgenes encoding chimeric
transcription factors were introduced into the Drosophila genome at the 86Fb locus on the 3rd
chromosome by the φC31 integrase-mediated transgenesis technique (Bischof et al., 2007).
The UAS-GFP (2nd chromosome) and UAS-lacZ (3rd chromosome) transgenes were used as
reporters.
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Figures
Figure 1 Model transcription factors used in this study.
Chimeric transcription factors were driven either by (A) the metal-inducible Drosophila
metallothionein B promoter, (B) the Drosophila Actin 5c promoter or (C) the yeast alcohol
dehydrogenase 1 (ADH1) promoter. 20Q, 40Q and 86Q denote polyQ stretches encoded by
CAG codons. 20 and 86 AGC codons encode 20 and 86 serines (20S and 86S). (D) Fusion
proteins used for mammalian two-hybrid studies. The constructs were expressed from the
strong enhancer/promoter of human cytomegalovirus.
PolyQ tract generally activates transcription
16 / 20
PolyQ tract generally activates transcription
17 / 20
Figure 2 PolyQs contribute to transcriptional activation in a length-dependent manner in
Drosophila cell culture, flies and yeast.
(A) Drosophila Kc cells were transfected with 20μg reporter plasmid, 10μg effector plasmid
(Figure 1A) and 5 μg reference plasmid. The expression of effector genes (Gal4DBD-nQ-
VP16AD80) was induced by supplementing cell growth media with CuSO4 to a final
concentration of 100 μM. 48 hours after induction, transcript levels of the 5xGal-OVEC
reporter and Actin-OVEC reference were determined by the S1 nuclease protection assay. ΔQ 
= no glutamines. (B) PolyQs boost reporter gene expression in transgenic flies. Freshly
eclosed flies of the genotype y w; UAS-GFP/+; Gal4DBD-nQ-VP16/+ were chloroform-
anesthetized and pictures of four fly abdomens for each genotype were taken with the same
exposure time (1200 ms). (C) For the quantitative liquid β-galactosidase assay in Drosophila,
3rd instar larvae of the genotype y w; Gal4DBD-nQ-VP16AD80/UAS-LacZ were collected. β-
galactosidase activity was measured in pools of three larvae. (D) Activity of chimeric
transcription factors (Figure 1C) in a yeast in vivo plate assay using X-gal in the medium. The
increasing blue color intensity of yeast cells indicates increasing activity of the transcription
factor that drives the expression of the LacZ reporter gene. (E) Quantitative β-galactosidase
assay in yeast liquid culture using ONPG as a substrate.
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Figure 3 PolyQs at the C-terminus also contribute to transactivation.
Drosophila S2 cells were transfected with 1 μg reporter plasmid, 10 μg effector plasmid
(Figure 1A and B) and 2.5 μg reference plasmid. The activity of transcription factors with a
polyQ stretch added to the C-terminus (Gal4DBD-Gal4AD-40Q or Gal4DBD-VP16AD80-
40Q), with a “linker” polyQ tract (Gal4DBD-40Q-Gal4AD or Gal4DBD-40Q-VP16AD80), or
without polyQ (Gal4DBD-Gal4AD or Gal4DBD-VP16AD80) was studied by measuring the
transcript levels of the 5xGal-OVEC reporter and Actin-OVEC reference by the S1 assay.
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Figure 4 Polyserine tracts do not contribute to transcription activation.
(A) Transcript levels of the 5xGal-OVEC reporter and CMV-OVEC reference in HEK293T
cells were determined by the S1 assay. Cells were transfected with 10 μg reporter plasmid,
5μg of Gal4DBD-nQ/nS-VP16AD80 effector constructs (Figure 1A) and 2 μg reference
plasmid. 500 μM CuSO4 was used to induce the MtnB promoter for 24 hours. (B) PolyQ and
polyserine in transgenic Drosophila larvae. 3rd instar larvae of genotype y w ; UAS-GFP/+ ;
Gal4DBD-nQ/nS-VP16AD80/+, were collected. Reporter activity was determined by the
liquid LacZ assay.
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Figure 5 Analysis of polyQ tract interactions in a mammalian two-hybrid system.
(A) HEK293T cells were transfected with 10 μg 5xGal-OVEC reporter, 4 μg of each of the
two-hybrid effector plasmids (Figure 1D) and 1 μg CMV-OVEC reference plasmid. Reporter
and reference gene transcripts were quantified by the S1 assay. (B) EMSA of a [32P]-labeled
Gal4-binding oligonucleotide with nuclear extracts of HEK293T cells transfected with 10 μg
of the ‘bait’ and ‘prey’ constructs each, demonstrating that DNA-binding is not affected by
polyQ length and that the binding of bait (Gal4DBD-ΔQ/26Q/74Q) remains unchanged in the
presence of prey (ΔQ/20Q/86Q-VP16AD). A bait-prey interaction as seen in vivo by the two-
hybrid assay (A) is not observed under EMSA conditions.
